Q4 2025 Milestone Scientific Inc Earnings Call Transcript
Key Points
- Milestone Scientific Inc (MLSS) has completed a restructuring process in 2025, allowing the company to focus on growth and investment in areas with clear returns.
- The company is seeing international growth in its Dental business, with the STA system gaining traction and new market opportunities in countries like Japan, India, and Mexico.
- CompuFlo, a patented system for precise epidural injections, is positioned as a transformative growth driver with expanding clinician interest and reimbursement efforts.
- The company has launched a national Dental Ambassador program to enhance market engagement and expects significant contributions to sales from this initiative.
- Milestone Scientific Inc (MLSS) has set a clear goal to reach cash flow breakeven by early 2027, demonstrating a focused approach to financial management and shareholder value.
- Despite a 2.2% increase in quarterly revenue, the growth remains modest, indicating potential challenges in accelerating sales momentum.
- Gross profit remained flat year-over-year, suggesting that changes in product mix and cost structure have not yet translated into improved profitability.
- The company continues to operate at a net loss, with a $1.1 million loss in the fourth quarter of 2025, highlighting ongoing financial challenges.
- Milestone Scientific Inc (MLSS) faces uncertainties in international market registrations, which could delay potential revenue contributions from new markets.
- The company acknowledges potential risks from tariffs and other external factors that could impact gross margins and overall financial performance.
Good day, everyone. Welcome to the Milestone Scientific Inc fourth quarter 2025 financial results and business update conference call. (Operator Instructions) As a reminder, this call is being recorded. It is now my pleasure to turn the floor over to your host, James Carbonara with Hayden IR. The floor is yours
Thank you, operator. Good day, everyone. Before we begin, please note that today's call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements are subject to risks and uncertainties that could cause actual results differ materially from those projected. Please refer to our earnings press release as well as our filings with the SEC, including our 2025 Form 10-K for a discussion of these risks. A replay of this call will be available shortly after its conclusion.
With that, I'll turn the call over to our CEO, Eric Hines.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
